(Reuters) Japan's Mitsubishi Tanabe Pharma Corp has agreed to buy Israeli drug maker Neuroderm for $1.1 billion. The Japanese drug maker said on Monday it was particularly attracted by Neuroderm's Parkinson's disease drug that is in advanced clinical trials.
2017-07-25 00:00:00Full ArticleBACK Visit the Daily Alert Archive